Targeted Therapy in Cancer

A continuing medical education activity sponsored by NAMCP and AAMCN
This activity was held live at the 2007 Fall Managed Care Forum.

This activity is valid from February 28, 2008 to March 1, 2009.
 

Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This activity is supported by an educational grant from Genentech


 PLEASE CLICK HERE TO VIEW PRESENTATION

 PLEASE CLICK HERE FOR POST TEST AND EVALUATION

Instructions for CME/CEU:  View the presentation, answer the post test, complete the evaluation form and submit to keads@namcp.org.  You will have the option on the post test/evaluation page to submit your forms electronically or by faxing them to Katie Eads at 804-747-5316.

Summary
Targeted cancer therapy is evolving rapidly and is changing the choice of regimen in many cancers from an empiric guess to a predictive choice. Although many agents are currently available, many more are in the development pipeline. Each of these agents targets one or more of the hallmarks that drive cancer growth. Although they may be somewhat less toxic then traditional chemotherapy, these agents are not without adverse effects.

Objectives

  • Identify how cancer treatment is evolving due to individualized medicine

  • Analyze clinical decision tools to manage patients

Faculty: Edward Lin, MD, Associate Professor Oncology Division, Seattle Cancer Care Alliance
   

Disclosure:

Dr. Lin receives research support from Bristol Myers Squibb, Pfizer, and Roche Laboratories. NAMCP CME committee determined this did not present a conflict of interest in regards to the content of his presentation.
 

Accreditation & Designation
The National Association of Managed Care Physicians (NAMCP) is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians. NAMCP designates this activity for a maximum of 1 AMA PRA Category I creditsTM. Each physician should claim credit commensurate with the extent of their participation in the activity.

The American Association of Managed Care Nurses (AAMCN) has been approved as a provider of continuing education by the Virginia Nurses Association (VNA) VNA is accredited as an approver of continuing education in nursing by the American Nurses Credentialing Center’s Commission on Accreditation. Nurses who complete this activity will be awarded 1.0 contact hours.

This activity has been approved by the American Board of Managed Care Nursing for 1.0 contact hours toward CMCN recertification requirements.  

This activity is supported by an educational grant from Genentech